Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

Peritonitis bacterial adverse event reports that record this term

Kind of term
MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 9,932 adverse event reports that record the MedDRA preferred term Peritonitis bacterial. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 573 reports in the 12 months to June 2026 and 430 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 917 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 573 (under 0.1%) record this term. Reports for male patients were 55.3% of the reports that record this term and 34.6% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 123 drug pages with 5 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports with the term Peritonitis bacterial name as a suspect product, in order of name
DrugClassReports with this term
AripiprazoleAtypical antipsychotic13
AvastinVascular endothelial growth factor inhibitor11
AzathioprinePurine antimetabolite18
Bendamustine6
BevacizumabVascular endothelial growth factor inhibitor16
Boceprevir11
BortezomibProteasome inhibitor10
Calcium11
Calcium Chloride Dextrose Magnesium Chloride Sodium Chloride35
Calcium Cl Dextrose Magnesium Cl Sodium Bicar Sodium Cl Sodium Lact55
CapecitabineNucleoside metabolic inhibitor5
CefazolinCephalosporin antibacterial9
CeftazidimeCephalosporin antibacterial10
CiprofloxacinFluoroquinolone antibacterial14
CisplatinPlatinum-based drug15
CitalopramSerotonin reuptake inhibitor5
ClofazimineAntimycobacterial9
Copegus15
CosentyxInterleukin-17A antagonist6
CyclophosphamideAlkylating drug38
CyclosporineCalcineurin inhibitor immunosuppressant7
Daclatasvir9
Daclatasvir dihydrochloride5
Daklinza6
DaratumumabCD38-directed cytolytic antibody6
DelflexOsmotic laxative939
Delflex with Dextrose 1 5% Low Magnesium Low Calcium1,202
Delflex with Dextrose 2 5% Low Magnesium Low Calcium1,527
Delflex with Dextrose 4 25% Low Magnesium Low Calcium538
DexamethasoneCorticosteroid15
Dextrose20
Dianeal1,576
Dianeal for Peritoneal Dialysis17
Dianeal Low Calcium1,395
Dianeal Low Calcium Peritioneal Dialysis Solution with 1 5%20
Dianeal Low Calcium Peritoneal Dialysis Solution with Dextrose1,937
Dianeal Low Calcium W/Dextrose 1 5%26
DIANEAL Low Calcium with DextroseOsmotic laxative11
Dianeal Pd-2 Peritoneal Dialysis Solution with Dextrose43
Dianeal Pd-2 W/Dextrose 1 5%55
DIANEAL PD-2 with DextroseOsmotic laxative199
Dianeal Pd2152
Dianeal Pd2 with 1 5% Dextrose10
Dianeal Pd2 with 4 25% Dextrose6
Dianeal Pd4 Solution with 1 5% Dextrose and 2 5 Meq/L Calcium29
Dianeal Pd4 Solution with 2 5% Dextrose and 2 5 Meq/L Calcium24
Dianeal Pd4 Solution with 4 25% Dextrose and 2 5 Meq/L Calcium7
Dianeal W/Dextrose 2 5%26
Dianeal with Dextrose6
DiclofenacNonsteroidal anti-inflammatory drug5
Doxorubicin hydrochlorideAnthracycline topoisomerase inhibitor5
EpclusaHepatitis C virus NS5A inhibitor17
ExtranealOsmotic laxative1,483
Exviera10
Flixotide17
FluorouracilNucleoside metabolic inhibitor19
Folinic Acid5
GemcitabineNucleoside metabolic inhibitor7
Gemcitabine hydrochlorideNucleoside metabolic inhibitor9
HarvoniHepatitis C virus NS5A inhibitor21
Heparin sodiumAnti-coagulant17
Humira17
Icodextrin70
Incivek5
Incivo9
Irinotecan5
Jakavi5
LamotrigineAnti-epileptic agent5
Ledipasvir and sofosbuvirHepatitis C virus NS5A inhibitor14
LenalidomideThalidomide analog8
LinezolidOxazolidinone antibacterial13
Low Calcium Peritoneal Dialysis Solution with 2 5% Dextrose5
Mabthera8
Magnesium11
MeropenemPenem antibacterial11
MetforminBiguanide13
Metformin hclBiguanide5
MethotrexateFolate analog metabolic inhibitor7
MethylphenidateCentral nervous system stimulant9
MethylprednisoloneCorticosteroid11
MontelukastLeukotriene receptor antagonist8
MoxifloxacinFluoroquinolone antibacterial9
Mycophenolate mofetilAntimetabolite immunosuppressant44
Mycophenolic acidAntimetabolite immunosuppressant15
NexavarKinase inhibitor12
NivolumabProgrammed death Receptor-1 blocking antibody7
Nutrineal17
Nutrineal Pd422
Ocaliva7
Olysio5
OxaliplatinPlatinum-based drug20
Peg-Interferon Alfa 2a15
Peg-Intron9
PegasysInterferon alpha32
Peginterferon alfa-2aInterferon alpha5
Peginterferon Alfa-2b10
Phenobarbital6
Physiosol in Plastic Container34
PrednisoloneCorticosteroid57
PrednisoneCorticosteroid71
PrografCalcineurin inhibitor immunosuppressant9
Rebetol24
Reguneal Hca21
Reguneal Lca81
RibavirinNucleoside analog antiviral132
RituximabCD20-directed cytolytic antibody24
SertralineSerotonin reuptake inhibitor9
Simeprevir7
SingulairLeukotriene receptor antagonist12
SofosbuvirHepatitis C virus nucleotide analog NS5B polymerase inhibitor54
SolirisComplement inhibitor11
SovaldiHepatitis C virus nucleotide analog NS5B polymerase inhibitor27
TacrolimusCalcineurin inhibitor immunosuppressant104
Telaprevir8
TheophyllineMethylxanthine21
Thymocyte Immune Globulin9
TocilizumabInterleukin-6 receptor antagonist6
TracleerEndothelin receptor antagonist8
VancomycinGlycopeptide antibacterial37
Victrelis8
Viekirax10
Vincristine sulfateVinca alkaloid5
XifaxanRifamycin antibacterial8

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 51 pharmacologic classes with 5 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Pharmacologic classes of the drugs that the reports with the term Peritonitis bacterial name, in order of name
ClassReports with this term
Alkylating drug38
Anthracycline topoisomerase inhibitor7
Anti-coagulant17
Anti-epileptic agent5
Antimetabolite immunosuppressant61
Antimycobacterial13
Atypical antipsychotic20
Azole antifungal7
Benzodiazepine8
Biguanide22
Calcineurin inhibitor immunosuppressant120
CD20-directed cytolytic antibody24
CD38-directed cytolytic antibody6
Central nervous system stimulant11
Cephalosporin antibacterial25
Complement inhibitor15
Corticosteroid160
Endothelin receptor antagonist17
Erythropoiesis-stimulating agent6
Fluoroquinolone antibacterial29
Folate analog metabolic inhibitor9
Glycopeptide antibacterial37
Hepatitis C virus NS5A inhibitor52
Hepatitis C virus nucleotide analog NS5B polymerase inhibitor81
Interferon alpha37
Interleukin-17A antagonist6
Interleukin-6 receptor antagonist6
Kinase inhibitor43
Leukocyte growth factor6
Leukotriene receptor antagonist20
Methylxanthine21
Microtubule inhibitor5
Nonsteroidal anti-inflammatory drug5
Nucleoside analog antiviral135
Nucleoside metabolic inhibitor44
Osmotic laxative2,632
Oxazolidinone antibacterial13
Penem antibacterial11
Phosphodiesterase 5 inhibitor6
Platinum-based drug39
Programmed death Receptor-1 blocking antibody17
Prostacycline vasodilator6
Proteasome inhibitor10
Purine antimetabolite21
Rifamycin antibacterial8
Serotonin reuptake inhibitor18
Thalidomide analog10
Thrombopoietin receptor agonist5
Tumor necrosis factor blocker12
Vascular endothelial growth factor inhibitor27
Vinca alkaloid5

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Peritonitis bacterial, by month, five years to June 2026
05010020222023202420252026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Peritonitis bacterial
AgeReportsShareShare as a bar
Under 2400.4%
2 to 111111.1%
12 to 17800.8%
18 to 449499.6%
45 to 642,69227.1%
65 to 741,72917.4%
75 and over1,16211.7%
Age not given3,16931.9%
Sex of the patient in the reports that record Peritonitis bacterial
SexReportsShareShare as a bar
Female4,15341.8%
Male5,49355.3%
Unknown or not given2862.9%

Age and sex are as the report gives them. 81.7% of these reports give the United States as the country.

Terms near this one

Official pages

The site checked these addresses on . The links open in a new tab.

Cite this page

Reported Reactions. Peritonitis bacterial: adverse event reports that record this term. https://reportedreactions.com/reaction/peritonitis-bacterial/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Peritonitis bacterial mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.

Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on .